title: Enhancement by dibutyryl cyclic AMP of voltage-dependent Ca2+ and K+ currents in the guinea-pig vas deferens.
abstract: This study was designed to investigate a possible role for intracellular cyclic AMP involved in agonist-induced changes in electrical activity of smooth muscle of the guinea-pig vas deferens. The action of dibutyryl adenosine 3', 5'-phosphate (dibutyryl cyclic AMP) (up to 30 microM) was examined in current- and voltage-clamp, using the double sucrose gap method. Under current-clamp, dibutyryl cyclic AMP clearly shortens the duration of action potential by hastening the rates of depolarization and of repolarization and increases the peak amplitude. Under voltage-clamp, dibutyryl cyclic AMP enhances the maximum ICa by increasing the conductance (ga), but without affecting its reversal potential (Ea) and kinetics in preparations in normal Krebs solution as well as in preparations in tetraethylammonium chloride loading solution. In normal Krebs solution, dibutyryl cyclic AMP also enhances the peak (Ib') and late outward K+ currents (Ib) by increasing the conductances (gb') and (gb), respectively. These results indicate that in vas deferens smooth muscle intracellular cyclic AMP may be of functional significance for activation of voltage-dependent peak and late IK channels as well as activation of voltage-dependent ICa channel.
authors.affiliation: Department of Applied Physiology, Tohoku University School of Medicine, Akita, Japan.
authors.forename: J J
authors.initials: JJ
authors.lastname: Ji
authors.forename: H
authors.initials: H
authors.lastname: Inomata
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D003994:Bucladesine / Q000378:metabolism / Q000494:pharmacology*; D015220:Calcium Channels / Q000187:drug effects* / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism / Q000502:physiology; D004553:Electric Conductivity; D006168:Guinea Pigs; D007700:Kinetics; D008297:Male; D018408:Patch-Clamp Techniques; D015221:Potassium Channels / Q000187:drug effects* / Q000378:metabolism; D019789:Tetraethylammonium; D013757:Tetraethylammonium Compounds / Q000378:metabolism; D014649:Vas Deferens / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology*
chemical_list: D015220:Calcium Channels; D015221:Potassium Channels; D013757:Tetraethylammonium Compounds; D003994:Bucladesine; D019789:Tetraethylammonium